Pj. Wilding et al., EFFECT OF CESSATION OF SHORT-TERM THERAPY WITH IPRATROPIUM BROMIDE ONLUNG FUNCTION AND AIRWAY RESPONSIVENESS, The European respiratory journal, 9(8), 1996, pp. 1627-1631
Regular exposure to antimuscarinic drugs would be expected to upregula
te airway muscarinic receptors and could cause a transient increase in
airways obstruction if treatment was stopped or omitted. We have exam
ined peak expiratory flow rate (PEFR) during treatment and forced expi
ratory flow in one second (FEV1) and airway responsiveness to three co
nstrictor agonists (as the provocative dose of agonist causing a 20% f
all in FEV1, (PD20)) following cessation of regular inhaled ipratropiu
m bromide, in 13 subjects with mild stable asthma. Subjects inhaled pl
acebo and ipratropium bromide, 80 mu g q.i.d. for 14 days in a cross-o
ver fashion with a 1 week run-in/wash-out period before and after each
treatment period. Subjects recorded symptom scores and PEFR throughou
t the study, and FEV1 and PD20 to histamine, methacholine and metabisu
lphite were measured before and after cessation of treatment. When com
pared to baseline, FEV1 was lower after cessation of ipratropium than
after placebo, with a significant difference 30 h after the last dose
(difference 190 mL; 95% confidence interval (95% CI) 310-70 mL; p<0.02
), FEV1 measured 6-10 days later, did not differ significantly. PEFR w
as significantly lower after cessation of ipratropium than after place
bo on Day 15 (19-37 h after the last dose) (mean difference 4.6%; 95%
CI 1.6-7.5%; p<0.01) but not on Day 16. There were no significant chan
ges in PD20 histamine, methacholine and metabisulphite, symptom scores
or rescue bronchodilator use after cessation of treatment. Thus, tran
sient bronchoconstriction was found around 30 h after cessation of reg
ular therapy with inhaled ipratropium for 2 weeks, The mechanism is un
clear, as no evidence of muscarinic receptor upregulation was found. A
lthough the changes were small and unlikely to be important for most p
atients, the results of this study indicate that the timing of lung fu
nction measurements relative to the last dose of ipratropium is import
ant when interpreting the course of lung function in long-term studies
.